MLKL attenuates colon inflammation and colitis-tumorigenesis via suppression of inflammatory responses
MLKL attenuates colon inflammation and colitis-tumorigenesis via suppression of inflammatory responses
复制标题
MLKL 通过抑制炎症反应减轻结肠炎症和结肠炎肿瘤发生
DOI:
10.1016/j.canlet.2019.05.034
复制
发表时间:
2019
期刊:
影响因子:
9.7
通讯作者:
Zhang Haibing
中科院分区:
文献类型:
--
作者:
Zhao Qun;Yu XianJun;Li Ming;Liu YongBo;Han YaMei;Zhang XiXi;Li Xiao Ming;Wu XiaoXia;Qin Jun;Fang Jing;Zhang Haibing
The mixed lineage kinase domain-like protein (MLKL) has emerged as a critical mediator of necroptosis, which results in the release of cellular damage-associated molecular patterns (DAMPs). However, its physiological role in regulating inflammation is not fully understood. We herein showed thatMlkl−/−mice were highly susceptible to colitis and colitis-associated tumorigenesis (CAT), which was associated with massive leukocyte infiltration and increased inflammatory responses. Moreover, we used bone marrow transplantation to reveal that MLKL in inflammatory cells is crucial for its role on colitis. Intestinal mucosal tissue and polyps isolated fromMlkl−/−mice exhibited increased ERK activation and elevated expression of genes associated with inflammation and cancer. Mechanistically, enhanced inflammation inMlkl−/−mice was due to MEK/ERK activation particularly in dendritic cells (DCs). Our results demonstrate the role of MLKL in maintaining intestinal homeostasis and protecting against colitis and tumorigenesis.